Related Experiment Video
Updated: Jun 13, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
[Successful desensitization protocol for patients with hypersensitivity reactions caused by carboplatin]
Shin Nishio1, Takahiro Koyanagi, Kyosuke Miyabe
1Department of Obstetrics and Gynecology, Social Insurance Tagawa Hospital.
Abstract:
We report the successful desensitization of a patient with a hypersensitivity reaction to carboplatin. A 54-year-old woman with advanced ovarian cancer went into remission after 10 courses of paclitaxel plus carboplatin (TC). After 7 months, cancer recurred in the vaginal cuff, and surgery was performed. Cancer recurred again in the vaginal cuff 6 months later, and she was administered TC. A hypersensitivity reaction attributed to carboplatin occurred during the third and fourth courses, and the drug was withdrawn. Because the initial response to TC was good, we decided to attempt desensitization to carboplatin. The desensitization procedure was successful, and the patient subsequently tolerated four additional courses of TC, with no further signs or symptoms of hypersensitivity. A complete response was achieved. A carboplatin desensitization regimen may allow patients with platinum-sensitive ovarian cancer to continue to benefit from therapy.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Desensitization and Tachyphylaxis
Several...
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Depolarizing Blockers: Pharmocokinetics
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
